MiR-375 is involved in the development and progression of ESCC by repressing metadherin expression.[39,40,43] In this study, higher expression levels of hsa-miR-9-3p and hsa-miR-34c-3p were found to be associated with poor OS in patients with ESCC. Here, MTDH is linked to esophageal squamous cell carcinoma.